Immediate Impact
1 from Science/Nature 44 standout
Citing Papers
Recent progress of CDK4/6 inhibitors’ current practice in breast cancer
2024 Standout
Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy
2024 Standout
Works of S. B. Kim being referenced
MonarcHER: A randomized phase II study of abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with HR+, HER2+ advanced breast cancer (ABC)
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| S. B. Kim | 24 | 9 | 42 | 31 | 6 | 84 | |
| Tanner Fullmer | 23 | 20 | 30 | 7 | 110 | ||
| B Karanfilski | 59 | 34 | 20 | 9 | 206 | ||
| Joel Berends | 17 | 36 | 33 | 7 | 67 | ||
| Marco Waleboer | 18 | 13 | 56 | 6 | 169 | ||
| Khaled Zaza | 35 | 30 | 55 | 8 | 108 | ||
| Yi-Shan Wu | 27 | 26 | 30 | 4 | 97 | ||
| Michele Nguyen | 10 | 73 | 35 | 7 | 107 | ||
| Fatih Özcan | 23 | 21 | 38 | 9 | 80 | ||
| J. P. Stewart | 42 | 1 | 13 | 17 | 10 | 92 | |
| J.Thornwell Witherspoon | 37 | 26 | 23 | 7 | 97 |
All Works
Login with ORCID to disown or claim papers
Loading papers...